Formosa Plastics Corporation (1301.TW)
Kaohsiung, TW
Formosa Plastics Corporation operates as a leading manufacturer and global supplier, producing plastic raw materials, chemical fibers, and a diverse range of petrochemical products. The company's reach extends throughout Taiwan, mainland China, and various international markets. Its extensive plastics portfolio encompasses materials such as PVC, high-density polyethylene (HDPE), linear low-density polyethylene (LLDPE), ethylene vinyl acetate (EVA) copolymer, polyethylene wax, polypropylene (PP), polyacetal, and various compound rubber particles. Beyond plastics, Formosa Plastics manufactures a broad spectrum of chemical substances. These include liquid caustic soda, solid alkali, liquid chlorine, vinyl chloride, dichloroethane, acrylonitrile, acetonitrile, methyl methacrylate, methacrylate, epichlorohydrin, methyl tertiary butyl ether (MTBE), acrylate, superabsorbent resin, and n-butanol. The corporation also develops and offers carbon fibers, in addition to providing advanced industrial computer systems for process control (DCS), warehouse logistics, real-time production management, safety monitoring, and laboratory information management. Further diversifying its offerings, Formosa Plastics supplies specialized items like dye-sensitized batteries, processing aids, impact modifiers, "haibo" products, chlorinated solvents, purified hydrogen, lithium-ion battery electrolytes, lime, calcium carbonate powder, hydrochloric acid, and antibacterial solutions. These versatile products are utilized across a wide array of applications and industries, including daily necessities, outdoor sports equipment, mechanical engineering, building materials and coatings, 3C home appliances, and various civil and agricultural livestock sectors. Formosa Plastics Corporation was established in 1954 and maintains its corporate headquarters in Kaohsiung, Taiwan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.11% | -9.71% | -15.19% | -2.13% | +8.23% | +18.08% | +24.80% | -50.43% | -51.78% | -40.35% | +63.53% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 2 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-12.3% Q1'26: -11.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-731.6% Q1'26: +5,000.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-3.8% Q1'26: -10.2% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-4.3% Q1'26: -3.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-2.0% Q1'26: -1.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.1% ★ Q1'26: +27.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×42.77× Q1'26: -25.11× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 2 EPS Ana. |
Dec 2027 4 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
191.55B
est: 192.31B (-0.4%)
|
180.17B
est: 187.33B (-3.8%)
|
206.71B
est: 201.32B (+2.7%)
|
230.37B
est: 225.20B (+2.3%)
|
207.85B
est: 214.05B (-2.9%)
|
185.81B
est: 185.15B (+0.4%)
|
273.60B
est: 273.08B (+0.2%)
|
251.65B
est: 249.22B (+1.0%)
|
199.14B
est: 197.70B (+0.7%)
|
200.04B
est: 198.36B (+0.8%)
|
175.41B
est: 177.74B (-1.3%)
|
164.30B
150.39B – 171.59B
-7.6% YoY
|
172.60B
162.51B – 183.09B
+5.1% YoY
|
184.29B
184.29B – 184.29B
+6.8% YoY
|
| EBITDA |
44.84B
est: 32.09B (+39.7%)
|
54.18B
est: 31.26B (+73.3%)
|
64.88B
est: 33.60B (+93.1%)
|
32.79B
est: 37.58B (-12.7%)
|
50.97B
est: 35.72B (+42.7%)
|
33.38B
est: 30.90B (+8.0%)
|
95.09B
est: 45.57B (+108.7%)
|
53.29B
est: 41.59B (+28.1%)
|
9.23B
est: 26.58B (-65.3%)
|
9.82B
est: 26.67B (-63.2%)
|
3.06B
est: 23.89B (-87.2%)
|
22.09B
20.22B – 23.07B
-7.6% YoY
|
23.20B
21.85B – 24.61B
+5.1% YoY
|
24.78B
24.78B – 24.78B
+6.8% YoY
|
| EBIT |
10.50B
est: 24.68B (-57.5%)
|
13.02B
est: 24.04B (-45.9%)
|
21.94B
est: 25.84B (-15.1%)
|
58.57B
est: 28.90B (+102.6%)
|
43.58B
est: 27.47B (+58.6%)
|
25.37B
est: 23.76B (+6.8%)
|
86.75B
est: 35.05B (+147.5%)
|
44.83B
est: 31.99B (+40.2%)
|
1.17B
est: 18.28B (-93.6%)
|
822.61M
est: 18.34B (-95.5%)
|
-7.51B
est: 16.43B (-145.7%)
|
15.19B
13.91B – 15.87B
-7.6% YoY
|
15.96B
15.03B – 16.93B
+5.1% YoY
|
17.04B
17.04B – 17.04B
+6.8% YoY
|
| Net Income |
30.88B
est: 31.00B (-0.4%)
|
39.39B
est: 34.54B (+14.0%)
|
49.38B
est: 45.86B (+7.7%)
|
49.55B
est: 54.64B (-9.3%)
|
37.32B
est: 39.65B (-5.9%)
|
20.04B
est: 18.68B (+7.2%)
|
71.36B
est: 70.21B (+1.6%)
|
36.14B
est: 39.52B (-8.6%)
|
7.34B
est: 5.36B (+37.0%)
|
-1.23B
est: -1.74B (+29.2%)
|
-10.05B
est: -10.05B (+0.0%)
|
4.03B
3.30B – 4.77B
+140.1% YoY
|
9.83B
6.12B – 13.70B
+143.5% YoY
|
18.39B
16.67B – 19.63B
+87.1% YoY
|
| SGA |
10.47B
est: 11.11B (-5.7%)
|
10.49B
est: 10.82B (-3.0%)
|
10.56B
est: 11.63B (-9.2%)
|
10.83B
est: 13.01B (-16.8%)
|
10.67B
est: 12.36B (-13.7%)
|
10.89B
est: 10.69B (+1.8%)
|
14.20B
est: 15.77B (-10.0%)
|
13.87B
est: 14.40B (-3.7%)
|
12.07B
est: 11.71B (+3.1%)
|
12.52B
est: 11.75B (+6.5%)
|
11.56B
est: 10.53B (+9.8%)
|
9.73B
8.91B – 10.16B
-7.6% YoY
|
10.22B
9.62B – 10.84B
+5.1% YoY
|
10.91B
10.91B – 10.91B
+6.8% YoY
|
| EPS |
4.85
est: 4.87 (-0.4%)
|
6.19
est: 5.43 (+14.1%)
|
7.76
est: 7.20 (+7.7%)
|
7.78
est: 8.58 (-9.4%)
|
5.86
est: 6.23 (-5.9%)
|
3.15
est: 2.94 (+7.3%)
|
11.21
est: 11.03 (+1.6%)
|
5.68
est: 6.28 (-9.5%)
|
1.15
est: 0.84 (+36.7%)
|
-0.19
est: -0.28 (+31.4%)
|
-1.58
est: -1.42 (-10.9%)
|
0.62
0.52 – 0.75
+143.5% YoY
|
1.54
0.96 – 2.15
+149.1% YoY
|
2.89
2.62 – 3.09
+87.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Taiwan ETF EWT | 0.53% | 56.42M | 0.59% |
| 2 | Franklin FTSE Taiwan ETF FLTW | 0.34% | 10.12M | 0.19% |
| 3 | HSBC ETFs Public Limited Company - HSBC MSCI Taiwan UCITS ETF HTWN.L | 0.32% | 345.3K | 0.50% |
| 4 | iShares MSCI Taiwan UCITS ETF IDTW.L | 0.31% | 4.81M | 0.74% |
| 5 | Xtrackers MSCI Taiwan UCITS ETF 1C XMTD.L | 0.31% | 1.46M | 0.65% |
| 6 | Schwab Fundamental Emerging Markets Large Company Index ETF FNDE | 0.30% | 28.68M | 0.39% |
| 7 | Franklin FTSE Taiwan UCITS ETF FLXT.MI | 0.30% | 1.95M | 0.19% |
| 8 | Invesco FTSE RAFI Emerging Markets UCITS ETF PSRM.L | 0.17% | 144.9K | 0.49% |
| 9 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.17% | 690.2K | 0.33% |
| 10 | iShares MSCI EM Islamic UCITS ETF ISDE.L | 0.15% | 1.14M | 0.35% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jerry Lin | President | 8M | male |
| Tony Liang | Executive Vice President | 6M | male |
| I-Chih Yeh | Deputy General Manager | 4M | male |
| Jung-Hung Kao | Deputy General Manager | 4M | male |
| Chao-Jung Chen | Deputy General Manager | 4M | male |
| Chi-Lin Wei | MD & Independent Director | 2M | male |
| Ruey-Yu Wang | MD & Executive Director | 50.0K | female |
| Wen-Chiao Wang | MD & Executive Director | 50.0K | male |
| Wen-Yuan Wong | MD & Executive Director | 50.0K | male |
| Zhen-Xiao Lei | Senior Vice President of Finance Division | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1301.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
